Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bahram Valamehr

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Science Translational Medicine|November 5, 2020
iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapyFrank Cichocki, Ryan Bjordahl, Svetlana Gaidarova, et al.
Nature Communications|November 29, 2022
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myelomaFrank Cichocki, Ryan Bjordahl, Jodie P Goodridge, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
Bispecific BAFF-R/BCMA CAR T cells control growth of heterogeneous plasma cells in multiple myelomaAgnese Fiori, Karin Zimmermann, Anna Li, et al.
Cell Stem Cell|June 5, 2025
Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacyMartin P Hosking, Soheila Shirinbak, Kyla Omilusik, et al.
Med (New York, N.Y.)|May 12, 2023
A chimeric antigen receptor uniquely recognizing MICA/B stress proteins provides an effective approach to target solid tumorsJohn Goulding, Wen-I Yeh, Bryan Hancock, et al.
Cell Stem Cell|September 15, 2021
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapyKarrune V Woan, Hansol Kim, Ryan Bjordahl, et al.
Journal for Immunotherapy of Cancer|November 1, 2022
Adaptive single-KIR<sup>+</sup>NKG2C<sup>+</sup> NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemiaAlvaro Haroun-Izquierdo, Marianna Vincenti, Herman Netskar, et al.
Blood|July 23, 2025
Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host diseaseLie Ma, Brent H Koehn, Michael C Zaiken, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Science Translational Medicine|November 5, 2020
iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapyFrank Cichocki, Ryan Bjordahl, Svetlana Gaidarova, et al.
Nature Communications|November 29, 2022
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myelomaFrank Cichocki, Ryan Bjordahl, Jodie P Goodridge, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
Bispecific BAFF-R/BCMA CAR T cells control growth of heterogeneous plasma cells in multiple myelomaAgnese Fiori, Karin Zimmermann, Anna Li, et al.
Cell Stem Cell|June 5, 2025
Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacyMartin P Hosking, Soheila Shirinbak, Kyla Omilusik, et al.
Med (New York, N.Y.)|May 12, 2023
A chimeric antigen receptor uniquely recognizing MICA/B stress proteins provides an effective approach to target solid tumorsJohn Goulding, Wen-I Yeh, Bryan Hancock, et al.
Cell Stem Cell|September 15, 2021
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapyKarrune V Woan, Hansol Kim, Ryan Bjordahl, et al.
Journal for Immunotherapy of Cancer|November 1, 2022
Adaptive single-KIR<sup>+</sup>NKG2C<sup>+</sup> NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemiaAlvaro Haroun-Izquierdo, Marianna Vincenti, Herman Netskar, et al.
Blood|July 23, 2025
Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host diseaseLie Ma, Brent H Koehn, Michael C Zaiken, et al.
Pageof 4